China National Accord Medicines Corp Ltd (200028) — Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd (200028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting HK$95.44 Million (capex HK$50.09 Million plus investments HK$45.35 Million) from operating cash flow of HK$1.83 Billion. Explore China National Accord Medicines Corp Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 27 annual periods. Also explore 200028 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. For live market cap and broader valuation context, see 200028 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (HKD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | HK$337.47 Million | HK$1.64 Billion | HK$217.35 Million | ▲ +41.3% |
| 2024 | 0.15x | HK$476.87 Million | HK$3.27 Billion | HK$282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | HK$457.64 Million | HK$2.94 Billion | HK$322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | HK$665.01 Million | HK$2.56 Billion | HK$322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | HK$514.46 Million | HK$1.66 Billion | HK$370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | HK$324.92 Million | HK$1.50 Billion | HK$293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | HK$301.17 Million | HK$2.00 Billion | HK$245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | HK$380.06 Million | HK$1.32 Billion | HK$255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | HK$217.09 Million | HK$1.29 Billion | HK$204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | HK$275.02 Million | HK$1.47 Billion | HK$265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | HK$226.73 Million | HK$1.05 Billion | HK$190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | HK$150.50 Million | HK$465.03 Million | HK$150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | HK$193.57 Million | HK$323.96 Million | HK$193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | HK$198.97 Million | HK$227.32 Million | HK$198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | HK$177.99 Million | HK$428.16 Million | HK$177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | HK$102.94 Million | HK$270.85 Million | HK$102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | HK$84.98 Million | HK$246.58 Million | HK$84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | HK$71.41 Million | HK$87.70 Million | HK$71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | HK$118.22 Million | HK$181.73 Million | HK$118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | HK$50.62 Million | HK$148.28 Million | HK$50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | HK$14.18 Million | HK$130.30 Million | HK$14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | HK$49.36 Million | HK$81.22 Million | HK$49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | HK$26.90 Million | HK$28.76 Million | HK$26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | HK$35.91 Million | HK$71.16 Million | HK$35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | HK$21.01 Million | HK$8.52 Million | HK$21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | HK$27.54 Million | HK$22.84 Million | HK$27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | HK$10.38 Million | HK$5.21 Million | HK$10.38 Million | — |